PPD Risk Assessment Using Methylation, Wearables, and Survey Data
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing risk predisposition to postpartum depression (PPD) are limited by their reliance on postpartum screenings, lack of integration with wearables data and survey data, and focus on a limited number of DNA methylation markers, leading to delayed identification and inadequate early intervention strategies.
Innovation Solution
A system and method that integrates DNA methylation markers with wearables data and self-reported information using machine learning to predict PPD risk, leveraging a dynamic self-learning platform for continuous improvement and personalized nutrition/lifestyle recommendations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If postpartum screenings are used to assess PPD risk, then the assessment can be performed using standardized tools, but the identification of high-risk women is delayed until after delivery
Solution Approach 1:
The patent performs PPD risk assessment during pregnancy using DNA methylation markers, wearables data, and survey data collected before delivery. This preliminary action enables identification of high-risk women during pregnancy rather than waiting for postpartum screenings, thus reducing the loss of time while maintaining assessment accuracy through multi-modal data integration
2Reliability
If only DNA methylation markers are used for PPD prediction, then the biological mechanism is well-defined, but the prediction accuracy is insufficient due to limited markers
Solution Approach 1:
The patent merges DNA methylation markers with wearables data (physical activity, sleep, heart rate) and survey data (psychological factors, social support) to create a comprehensive PPD risk assessment model. This combination of multiple data types enhances prediction accuracy by capturing both biological and environmental factors contributing to PPD risk
3Loss of time
If a comprehensive platform integrating multiple data sources is used, then early and accurate PPD identification is enabled, but the system complexity increases
Solution Approach 1:
The patent creates a universal platform that handles multiple data types (DNA methylation, wearables, surveys) through standardized processing pipelines. The system performs multiple functions including data collection, integration, risk calculation, and personalized recommendation generation, enabling early PPD identification while managing complexity through a unified multi-functional architecture
Data Source
AI summary
A method for computing predisposition risk for postpartum depression of an individual female human based at least on methylation is provided. The method comprises receiving, by a computing device, methylation data for an individual female human, the methylation data describing at least DNA methylation markers in the human. The method also comprises receiving, by the device, wearables data for the female, and receiving survey data provided by the female. The method also comprises applying, by the computing device, at least a risk predictor model builder and a risk predisposition assessment prediction algorithm to at least the received data to predict a risk predisposition to postpartum depression of the individual female. The method also comprises the computer identifying methylation markers causal to postpartum depression in the methylation data. The computer generates a personalized report describing methylation markers causal to postpartum depression, the markers identified at least in the received data.